Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Breast 2

Conditions

Brain Neoplasms 3Breast Neoplasms 2Triple Negative Breast Neoplasms 1Recurrence 1Glioma 1Glioblastoma 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × paclitaxel-Angiopep-2 conjugate × Clear all
NCT01967810 2020-02-25

ANG1005 in Patients With Recurrent High-Grade Glioma

Angiochem Inc

Phase 2 Completed
73 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Recurrence

NCT02048059 2020-02-25

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Angiochem Inc

Phase 2 Completed
72 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01480583 2016-07-13

GRABM-B

Angiochem Inc

Phase 2 Completed
85 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡